The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results.

G. Wang (Beijing, China)

Source: International Congress 2017 – Interventional pulmonology highlights 2017
Session: Interventional pulmonology highlights 2017
Session type: Oral Presentation
Number: 1465
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Wang (Beijing, China). The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results.. 1465

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016


RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021



LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT)
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves for the treatment of severe emphysema
Source: Annual Congress 2008 - New trends in interventional pulmonology
Year: 2008


European multicenter, blinded and randomized study design to evaluate the effectiveness of bronchoscopic airway valve placement for the treatment of advanced emphysema
Source: Annual Congress 2007 - Interventional bronchoscopy
Year: 2007


A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019
Year: 2019



Interim results on European multi-center trial to evaluate the clinical utility of arteriovenous fistulae for treatment of severe COPD
Source: Annual Congress 2010 - Interventions for obstructive lung diseases
Year: 2010


Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021



Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT)
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017



STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Abediterol in stable asthma:efficacy, safety and tolerability results from a Phase II, randomised, crossover study
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017


Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
Source: ERJ Open Res 2016: 00055-2016
Year: 2016



Lung volume reduction coil treatment for patients with severe heterogeneous emphysema, a multicenter feasibility trial
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011